Relationship to provide more streamlined, cost-effective approach to patient data entry
HORSHAM, Pa.--(BUSINESS WIRE)-- NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII) and a leading provider of healthcare information systems and connectivity solutions, today announced a reseller agreement with Nuance Communications, Inc. (NASDAQ: NUAN), a leading provider of speech-driven clinical documentation, clinical language understanding and analytics solutions to more than 450,000 physicians and 10,000 healthcare institutions worldwide.
Under the agreement, NextGen Healthcare will resell Nuance’s Dragon Medical speech recognition software to its NextGen® Ambulatory EHR clients, enabling physicians and administrators to navigate, dictate and correct medical documents by voice, directly within the electronic health record (EHR). Dragon Medical software is currently used by more than 180,000 clinicians worldwide. By incorporating the software as part of the NextGen Ambulatory EHR workflow, healthcare organizations can:
- Improve physicians’ clinical documentation productivity;
- Minimize time and costs associated medical transcription;
- Drive appropriate levels of reimbursement through more complete documentation;
- Increase patient engagement by enabling providers to capture data at a discrete level; and,
- Enhance the quality of clinical notes to facilitate better care coordination.
“Dragon Medical provides physicians and their staff the freedom to incorporate high-value, customized narratives as part of patients’ medical records,” said Janet Dillione, executive vice president and general manager of Nuance Healthcare. “Together, advanced voice and language understanding solutions make it possible to capture the complete patient story and enable unprecedented access and interaction with the data that has been captured. We believe this collaboration with EHR leader NextGen Healthcare will bring far-reaching benefits to its diverse client base.”
“With healthcare reform initiatives such as Meaningful Use and Accountable Care Organizations (ACOs) continually emerging and evolving, the ability to collect patient data in a discrete manner is perhaps now more important than ever,” noted Scott Decker, president of NextGen Healthcare. “The comprehensive reporting capabilities offered by NextGen Ambulatory EHR are best utilized when discrete data is not only accessible but also stored in the proper format. Leveraging Nuance technology will provide our clients the flexibility needed to capture patient data and effectively populate it through our powerful reporting engine. We believe that Dragon Medical will complement and enhance the breadth and depth of our EHR capability.”
About Nuance Healthcare
Nuance Healthcare, a division of Nuance Communications, is the market leader in providing clinical understanding solutions that accurately capture and transform the patient story into meaningful, actionable information. Thousands of hospitals, providers and payers worldwide trust Nuance voice-enabled clinical documentation and analytics solutions to facilitate smarter, more efficient decisions across the healthcare enterprise. These solutions are proven to increase clinician satisfaction and HIT adoption, supporting organizations to achieve Meaningful Use of EHR systems and transform to the accountable care model. Recognized as “Best-in-KLAS” 2004-2011 for Voice Recognition we invite you to learn more, http://www.nuance.com/for-healthcare/index.htm.
Connect with Nuance Healthcare on:
For the Health of IT blog: http://nuancehealthcareblog.com/
About NextGen Healthcare
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc., provides integrated clinical, financial and connectivity solutions for ambulatory, inpatient and dental provider organizations. For more information, please visit www.nextgen.com and www.qsii.com. Follow NextGen Healthcare on Twitter at www.twitter.com/nextgen or Facebook at http://www.facebook.com/NextGenHealthcare.
This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future (including, without limitation, statements concerning revenue and net income), are forward-looking statements within the meaning of these laws and involve a number of risks and uncertainties. Management believes that these forward-looking statements are reasonable and are based on reasonable assumptions and forecasts, however, undue reliance should not be placed on such statements that speak only as of the date hereof. Moreover, these forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, actual results may vary materially from those anticipated by the forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: volume and timing of systems sales and installations; length of sales cycles and installation process; the possibility that the products will not achieve market acceptance; seasonal patterns of sales and customer buying behavior; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; uncertainties concerning threatened, pending and new litigation against the Company including related professional services fees; uncertainties concerning the amount and timing of professional fees incurred by the Company generally; changes of accounting estimates and assumptions used to prepare the prior periods' financial statements; general economic conditions; and the risk factors detailed from time to time in Quality Systems' periodic reports and registration statements filed with the Securities and Exchange Commission. A significant portion of the Company's quarterly sales of software product licenses and computer hardware is concluded in the last month of the fiscal quarter, generally with a concentration of such revenues earned in the final ten business days of that month. Due to these and other factors, the Company's revenues and operating results are very difficult to forecast. A major portion of the Company's costs and expenses, such as personnel and facilities, are of a fixed nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues typically results in lower profitability or losses. As a result, comparison of the Company's period-to-period financial performance is not necessarily meaningful and should not be relied upon as an indicator of future performance. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.
Copyright © 2012 NextGen Healthcare Information Systems, Inc. All rights reserved.
NextGen and NextPen are either registered trademarks or trademarks of NextGen Healthcare Information Systems, Inc. in the United States and/or other countries. All other names and marks are property of their respective owners.
Michelle Rovner, 215-657-7010
KEYWORDS: United States North America Pennsylvania
INDUSTRY KEYWORDS: Technology Data Management Hardware Software Practice Management Health Managed Care